Check out our most popular compounded medications! Get Started
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded topical gel containing coal tar solution, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved (NDA or ANDA) product containing coal tar is listed. Products containing it are filed in the directory as over-the-counter monograph drugs, in shampoo, ointment, lotion or shampoo, soap and cream forms. None of the listed products containing coal tar is in gel form.
Gel bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Coal tar is a topical agent for psoriasis, seborrheic dermatitis and dandruff that compounding pharmacies prepare in topical forms by prescription.
Coal tar is a complex mixture produced from coal and has long been applied to the skin. Reviews describe it as a ligand of the aryl hydrocarbon receptor, a skin sensor that, when activated, strengthens skin barrier function and dampens inflammatory signaling, which may explain its use in psoriasis and atopic dermatitis. Coal tar is sold over the counter under the FDA monograph for dandruff, seborrheic dermatitis and psoriasis drug products, which permits labeling for relief of symptoms such as itching, scaling, flaking and redness; manufactured examples include MG217 Psoriasis ointment and coal tar shampoos. There is no FDA-approved prescription coal tar product on DailyMed. A prescriber might order coal tar compounded in a strength or base not sold over the counter, or combined with another active ingredient. Compounded preparations are not FDA-approved and require a prescription.
Coal tar has no boxed warning. It is for external use only; keep it out of the eyes. It can make skin more prone to sunburn for up to 24 hours after use, so use caution in sunlight. The monograph and labels say not to use it for long periods, on large areas, or in or around the rectum, genital area or groin without asking a doctor, and not to combine it with other psoriasis treatments such as ultraviolet light or prescription drugs unless directed. Stop and call your prescriber if it worsens or does not improve. Some over-the-counter coal tar labels, such as MG217, carry a California Proposition 65 cancer warning. LactMed reports a nursing infant can absorb coal tar components through contact with treated skin, prefers other treatments while breastfeeding, and advises treating the smallest area. Talk to your prescriber or pharmacist about side effects.
Furue and colleagues describe medicinal coal tar as activating both the aryl hydrocarbon receptor (AHR/ARNT) and the NRF2 antioxidative pathway; coal tar inhibits IL-4 and IL-13 driven STAT6 activation and promotes AHR-dependent skin barrier repair in atopic dermatitis. Regulatory status: 21 CFR Part 358 Subpart H lists coal tar as a monograph active ingredient for dandruff, seborrheic dermatitis and psoriasis, and requires sunlight, prolonged-use, anogenital (for leave-on products) and concomitant-psoriasis-therapy warnings; if a coal tar solution, derivative or fraction is used, its identity and concentration must be stated. The monograph covers coal tar only for dandruff, seborrheic dermatitis and psoriasis; Furue and colleagues describe medicinal coal tar use in atopic dermatitis, which is not a monograph or FDA-approved indication. Counsel on photosensitivity, and avoid concurrent phototherapy unless directed. Limit treated area during breastfeeding. Dosing is per prescriber. Coal tar is not a controlled substance.
Wash your hands. Apply the amount on your label to clean, dry skin and spread it in a thin layer. For a metered pump, your label states the number of presses. For a dosing syringe, push the plunger to the mark. Let the gel dry before covering with clothing. Wash your hands afterward and keep the site from touching other people until it has dried. Do not apply to broken skin unless told to.
A gel can have a nonaqueous or a water-based base, and USP <795> sets its default beyond-use date by water content, not by the word gel. A nonaqueous gel usually carries a beyond-use date of up to 180 days at room temperature or refrigerated. A water-based gel carries up to 35 days with a preservative, or 14 days refrigerated without one. Your label states which applies. Keep the container closed, away from heat and open flame if it contains alcohol, out of reach of children, and discard after the beyond-use date on your label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
